State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 351 actively recruiting studies with Michigan sites out of 351 registered in total. The busiest research areas in Michigan are Breast Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (64), Phase 2 (108), Phase 3 (88), Phase 4 (12).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 351 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 351. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT05330221 N/A
Recruiting
Project 2: ACHIEVE- HF
Condition
Heart Failure
Enrollment
364 pts
Location
United States
Sponsor
Henry Ford Health System
NCT07493265 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Condition
Narcolepsy
Enrollment
64 pts
Location
United States, Belgium, Canada
Sponsor
Eisai Inc.
NCT06150599 N/A
Recruiting
Sacral Neuromodulation for Chronic Pelvic Pain
Condition
Chronic Pelvic Pain Syndrome
Enrollment
25 pts
Location
United States
Sponsor
Corewell Health East
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT01973881 N/A
Recruiting
Quantitative MRI for Myelofibrosis
Condition
Myelofibrosis
Enrollment
192 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT06482567 N/A
Recruiting
Promoting Improved Functioning Among People Experiencing Stressful Situations
Condition
Acute Stress Reaction
Enrollment
450 pts
Location
United States
Sponsor
University of North Carolina,
NCT05755919 N/A
Recruiting
Functional Brain Mapping for Patients with Epilepsy
Condition
Epilepsy
Enrollment
80 pts
Location
United States
Sponsor
Wayne State University
NCT06616194 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With ...
Condition
Migraine
Enrollment
200 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06563895 Phase 3
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) S...
Condition
Amyloidosis
Enrollment
587 pts
Location
United States, Argentina, Australia
Sponsor
Eidos Therapeutics, a BridgeBi
NCT05763251 N/A
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Condition
Invasive Candidiasis
Enrollment
420 pts
Location
United States, Australia
Sponsor
Arkansas Children's Hospital R
NCT06564831 N/A
Recruiting
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard...
Condition
Diabetic Foot Ulcer
Enrollment
124 pts
Location
United States
Sponsor
Applied Biologics, LLC
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT06401356 Phase 3
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Condition
Hematologic Malignancy
Enrollment
50 pts
Location
United States, Belgium, Italy
Sponsor
Novartis Pharmaceuticals
NCT07335562 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleu...
Condition
Systemic Sclerosis
Enrollment
92 pts
Location
United States, Belgium, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
NCT04184973 N/A
Recruiting
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Condition
Rectal Cancer
Enrollment
250 pts
Location
United States, Germany, Israel
Sponsor
Colospan Ltd.
NCT06138873 N/A
Recruiting
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients...
Condition
Ventricular Tachycardia
Enrollment
100 pts
Location
United States
Sponsor
Rush University Medical Center
NCT06539988 N/A
Recruiting
Advancing Decisions About Virtual Service Encounters
Condition
Health Care Costs
Enrollment
600 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04986423 Phase 2
Recruiting
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castrat...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
200 pts
Location
United States, China
Sponsor
Zenith Epigenetics
NCT07409103 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat ...
Condition
Active Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, South Africa
Sponsor
Elevara Medicines Limited
NCT03836482 N/A
Recruiting
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
Condition
Acute on Chronic Systolic Congestive Heart Failure
Enrollment
20 pts
Location
United States
Sponsor
SeaStar Medical
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT07556718 Phase 2
Recruiting
Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
Condition
Quiescent Crohn's Disease (CD)
Enrollment
100 pts
Location
United States
Sponsor
University of Michigan
NCT06455449 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Su...
Condition
Polymyositis, Dermatomyositis
Enrollment
240 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT06107738 Phase 2
Recruiting
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell ...
Condition
Multiple Myeloma
Enrollment
60 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology